Researchers have identified three major molecular subtypes of Alzheimer's disease (AD) using data from RNA sequencing. The study advances our understanding of the mechanisms of AD and could pave the way for developing novel, personalized therapeutics. The work was published in Science Advances.
Alzheimer's disease is the most common form of dementia, but it is quite diverse in its biological and pathological manifestations. There is growing evidence that disease progression and responses to interventions differ significantly among Alzheimer's patients. Some patients have slow cognitive decline while others decline rapidly; some have significant memory loss and an inability to remember new information while others do not; and some patients experience psychosis and/or depression associated with AD while others do not.
"Such differences strongly suggest there are subtypes of AD with different biological and molecular factors driving disease progression," said the lead author of the study.
To identify the molecular subtypes of AD, the researchers used a computational biology approach to illuminate the relationships among different types of RNA, clinical and pathological traits, and other biological factors that potentially drive the disease's progress. The research team analyzed RNA-sequencing data of more than 1,500 samples across five brain regions from hundreds of deceased patients with AD and normal controls, and identified three major molecular subtypes of AD. These AD subtypes were independent of age and disease stage, and were replicated across multiple brain regions in two cohort studies.
These subtypes correspond to different combinations of multiple dysregulated biological pathways leading to brain degeneration. Tau neurofibrillary tangle and amyloid-beta plaque, two neuropathological hallmarks of AD, are significantly increased only in certain subtypes.
Many recent studies have shown that an elevated immune response may help cause Alzheimer's. However, more than half of AD brains don't show increased immune response compared to normal healthy brains. The analysis further revealed subtype-specific molecular drivers in AD progression in these samples. The research also identified the correspondence between these molecular subtypes and the existing AD animal models used for mechanistic studies and for testing candidate therapeutics, which may partially explain why a vast majority of drugs that succeeded in certain mouse models failed in human AD trials, which likely had participants belonging to different molecular subtypes.
Although the subtyping described by the researchers was performed post mortem using the patients' brain tissue, the researchers said that if the findings were validated by future studies, they could lead to the identification in living patients of biomarkers and clinical features associated with these molecular subtypes and earlier diagnosis and intervention.
"Our systematic identification and characterization of the robust molecular subtypes of AD reveal many new signaling pathways dysregulated in AD and pinpoint new targets," said the lead, "These findings lay down a foundation for determining more effective biomarkers for early prediction of AD, studying causal mechanisms of AD, developing next-generation therapeutics for AD and designing more effective and targeted clinical trials, ultimately leading to precision medicine for AD. The remaining challenges for future research include replication of the findings in larger cohorts, validation of subtype specific targets and mechanisms, identification of peripheral biomarkers and clinical features associated with these molecular subtypes."
https://advances.sciencemag.org/content/7/2/eabb5398
http://sciencemission.com/site/index.php?page=news&type=view&id=publications%2Fmolecular-subtyping-of&filter=22
Alzheimer's subtyping using RNA sequencing data
- 1,015 views
- Added
Edited
Latest News
A new autoinflammatory dise…
By newseditor
Posted 30 Mar
Molecular process involving…
By newseditor
Posted 30 Mar
Synthetic gene drives as an…
By newseditor
Posted 30 Mar
Two subtypes of insulin-pro…
By newseditor
Posted 28 Mar
Virtual reality-based real-…
By newseditor
Posted 28 Mar
Other Top Stories
Mechanics of autophagosome formation!
Read more
New computational tool to predict allosteric sites on a protein
Read more
A protein that transports NAD into mitochondria identified!
Read more
Sex difference in the gene expression across human tissues
Read more
Heart Cells Depend on Immune Cells to Clean-Up Their Junk!
Read more
Protocols
A quantitative fluorescence…
By newseditor
Posted 28 Mar
High-efficiency pharmacogen…
By newseditor
Posted 11 Mar
A combinatorial panel for f…
By newseditor
Posted 03 Mar
Deconstructing body axis mo…
By newseditor
Posted 22 Feb
Transcription factor bindin…
By newseditor
Posted 21 Feb
Publications
Constitutively active Lyn k…
By newseditor
Posted 30 Mar
Brain p3-Alcb peptide resto…
By newseditor
Posted 30 Mar
Molecular process involving…
By newseditor
Posted 30 Mar
Arrestin-dependent nuclear…
By newseditor
Posted 30 Mar
β2ARs: double edge sword in…
By newseditor
Posted 30 Mar
Presentations
Hydrogels in Drug Delivery
By newseditor
Posted 12 Apr
Lipids
By newseditor
Posted 31 Dec
Cell biology of carbohydrat…
By newseditor
Posted 29 Nov
RNA interference (RNAi)
By newseditor
Posted 23 Oct
RNA structure and functions
By newseditor
Posted 19 Oct
Posters
ASCO-2020-HEALTH SERVICES R…
By newseditor
Posted 23 Mar
ASCO-2020-HEAD AND NECK CANCER
By newseditor
Posted 23 Mar
ASCO-2020-GENITOURINARY CAN…
By newseditor
Posted 23 Mar
ASCO-2020-GENITOURINARY CAN…
By newseditor
Posted 10 Mar
ASCO-2020-GYNECOLOGIC CANCER
By newseditor
Posted 10 Mar